| RO-3306 |
ENSG00000088970.11 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000100181.17 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000118412.8 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000118412.8 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000124835.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000125804.9 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000145063.10 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000153363.8 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000153363.8 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000157152.12 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000160336.10 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000168367.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000170161.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000170590.4 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000175147.7 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000175147.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000175701.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000176728.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000177822.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000177993.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000178803.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000178803.6 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000178977.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000179219.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000180712.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000181798.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000182057.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000182376.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000185186.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000185186.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000185495.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000185837.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000185904.7 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000186056.5 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000188185.7 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000188206.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000188660.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000189223.9 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000196421.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000196668.3 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000197462.3 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000197813.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000198106.7 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000198221.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000198468.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000203266.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000203325.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000203441.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000203497.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000203497.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000203706.4 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000203999.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000204055.4 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000204362.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000204581.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000204623.4 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000204802.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000204815.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000204934.6 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000205054.2 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000205662.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000205663.5 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000205663.5 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000206129.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000206140.5 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000206142.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000206176.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000206195.6 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000206417.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000212552.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000212694.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000213468.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000213468.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000213793.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000213904.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000214851.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000214870.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000214922.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000215068.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000215159.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000215304.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000215386.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000215447.3 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000215458.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000215458.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000215908.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000217258.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000219665.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000221817.5 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000222041.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000222043.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000222044.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000223379.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000223379.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000223380.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000223393.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000223393.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000223396.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000223396.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000223442.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000223475.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000223477.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000223523.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000223537.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000223561.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000223576.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000223635.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000223642.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000223652.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000223653.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000223685.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000223697.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000223714.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000223725.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000223734.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000223768.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000223784.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000223784.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000223791.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000223791.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000223813.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000223839.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000223839.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000223842.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000223884.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000223891.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000223935.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000223975.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000224000.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000224079.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000224081.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000224086.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000224142.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000224165.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000224276.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000224356.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000224358.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000224384.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000224409.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000224441.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000224468.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000224481.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000224509.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000224533.3 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000224536.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000224541.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000224541.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000224609.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000224687.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000224698.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000224699.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000224700.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000224707.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000224713.3 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000224790.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000224794.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000224804.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000224810.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000224822.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000224843.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000224844.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000224905.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000224932.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000225037.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000225037.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000225057.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000225092.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000225096.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000225177.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000225205.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000225210.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000225210.5 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000225218.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000225218.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000225278.3 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000225300.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000225393.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000225408.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000225442.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000225446.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000225472.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000225493.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000225506.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000225511.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000225555.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000225613.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000225643.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000225706.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000225721.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000225725.4 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000225806.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000225836.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000225836.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000225857.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000225882.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000225891.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000225931.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000225945.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000225953.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000225964.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000225975.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000225981.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000226007.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000226007.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000226029.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000226089.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000226200.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000226240.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000226352.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000226383.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000226434.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000226445.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000226453.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000226453.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000226455.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000226471.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000226471.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000226505.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000226578.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000226669.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000226684.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000226690.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000226711.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000226747.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000226754.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000226756.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000226756.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000226803.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000226851.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000226852.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000226853.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000226883.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000226883.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000226891.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000226904.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000226920.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000226969.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000226969.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000226985.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000227070.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000227116.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000227215.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000227218.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000227218.3 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000227359.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000227363.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000227372.6 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000227372.6 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000227372.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000227373.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000227375.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000227409.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000227409.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000227431.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000227431.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000227477.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000227492.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000227502.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000227512.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000227527.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000227591.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000227598.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000227619.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000227673.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000227681.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000227695.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000227704.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000227704.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000227711.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000227719.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000227895.4 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000227938.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000227963.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000228010.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000228028.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000228060.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000228060.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000228150.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000228172.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000228192.3 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000228242.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000228294.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000228294.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000228294.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000228302.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000228323.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000228352.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000228386.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000228389.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000228397.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000228423.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000228478.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000228485.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000228486.5 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000228544.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000228624.3 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000228630.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000228634.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000228661.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000228742.5 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000228748.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000228763.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000228763.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000228775.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000228779.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000228793.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000228801.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000228802.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000228838.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000228886.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000228918.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000228933.3 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000228933.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000228956.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000228956.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000229043.2 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000229043.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000229105.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000229109.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000229152.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000229195.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000229203.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000229228.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000229261.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000229262.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000229325.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000229373.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000229487.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000229494.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000229498.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000229512.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000229521.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000229536.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000229539.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000229587.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000229645.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000229656.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000229688.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000229692.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000229692.3 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000229694.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000229739.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000229839.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000229841.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000229874.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000229893.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000229901.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000229931.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000229931.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000229955.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000229956.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000229970.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000229990.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000230002.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000230074.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000230084.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000230091.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000230176.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000230285.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000230289.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000230290.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000230319.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000230417.6 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000230439.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000230461.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000230479.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000230487.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000230487.3 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000230534.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000230536.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000230542.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000230552.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000230555.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000230606.6 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000230641.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000230648.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000230699.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000230709.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000230730.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000230736.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000230751.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000230790.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000230825.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000230826.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000230844.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000230844.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000230880.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000230896.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000230896.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000230914.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000230923.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000230937.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000230937.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000231050.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000231064.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000231073.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000231083.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000231092.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000231104.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000231119.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000231154.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000231154.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000231160.5 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000231187.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000231217.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000231233.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000231242.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000231249.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000231273.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000231291.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000231327.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000231346.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000231355.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000231441.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000231486.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000231519.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000231574.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000231609.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000231628.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000231628.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000231638.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000231646.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000231666.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000231691.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000231711.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000231731.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000231756.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000231760.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000231768.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000231811.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000231840.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000231871.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000231890.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000231908.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000231969.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000231977.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000232006.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000232023.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000232043.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000232044.4 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000232082.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000232104.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000232116.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000232117.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000232224.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000232224.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000232233.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000232259.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000232295.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000232342.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000232377.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000232377.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000232442.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000232442.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000232470.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000232545.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000232564.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000232611.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000232611.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000232611.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000232623.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000232640.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000232648.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000232656.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000232656.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000232692.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000232693.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000232698.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000232762.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000232912.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000232931.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000232936.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000232956.4 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000232973.7 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000232995.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000233006.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000233013.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000233033.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000233061.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000233077.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000233178.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000233207.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000233215.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000233244.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000233246.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000233250.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000233251.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000233296.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000233521.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000233540.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000233593.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000233602.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000233611.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000233611.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000233635.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000233635.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000233642.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000233651.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000233672.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000233783.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000233806.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000233806.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000233825.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000233844.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000233860.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000233862.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000233891.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000233895.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000233903.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000233912.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000233967.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000233968.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000234084.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000234139.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000234155.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000234193.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000234210.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000234215.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000234232.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000234235.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000234235.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000234277.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000234286.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000234292.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000234318.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000234327.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000234350.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000234352.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000234390.4 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000234432.3 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000234478.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000234492.4 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000234497.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000234504.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000234610.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000234661.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000234678.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000234753.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000234817.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000234871.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000234884.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000234943.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000234996.3 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000235021.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000235023.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000235052.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000235066.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000235078.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000235126.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000235126.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000235131.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000235172.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000235172.3 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000235192.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000235192.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000235214.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000235244.3 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000235245.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000235257.4 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000235280.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000235296.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000235298.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000235298.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000235313.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000235314.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000235319.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000235326.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000235426.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000235453.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000235481.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000235488.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000235493.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000235494.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000235497.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000235499.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000235501.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000235529.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000235545.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000235610.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000235641.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000235641.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000235652.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000235659.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000235663.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000235760.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000235770.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000235770.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000235772.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000235777.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000235781.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000235781.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000235806.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000235806.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000235872.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000235872.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000235884.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000235884.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000235890.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000235903.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000235904.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000235910.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000235954.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000236017.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000236021.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000236051.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000236051.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000236064.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000236066.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000236078.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000236095.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000236194.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000236212.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000236268.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000236269.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000236305.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000236310.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000236337.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000236426.3 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000236463.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000236472.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000236494.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000236514.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000236548.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000236558.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000236627.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000236711.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000236711.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000236711.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000236772.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000236833.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000236842.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000236901.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000236901.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000237149.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000237152.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000237222.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000237222.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000237232.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000237280.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000237331.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000237356.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000237357.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000237404.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000237422.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000237489.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000237499.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000237505.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000237523.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000237525.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000237594.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000237595.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000237595.2 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000237605.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000237646.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000237685.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000237686.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000237705.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000237705.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000237721.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000237738.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000237738.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000237764.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000237768.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000237781.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000237813.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000237813.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000237886.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000237892.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000237919.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000237928.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000237943.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000237976.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000237978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000237993.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000238043.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000238045.5 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000238057.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000238120.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000238122.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000238123.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000238164.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000238178.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000238186.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000238250.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000238260.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000239213.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000239377.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000239462.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000239462.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000239552.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000239653.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000239774.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000239911.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000239920.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000240143.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000240291.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000240350.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000240350.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000240373.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000240401.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000240423.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000240476.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000240535.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000240758.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000240770.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000240875.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000241180.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000241180.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000241280.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000241288.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000241288.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000241316.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000241472.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000241481.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000241570.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000241599.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000241732.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000241818.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000241954.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000242078.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000242094.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000242104.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000242136.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000242147.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000242349.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000242569.3 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000242641.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000242770.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000243069.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000243083.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000243176.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000243433.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000243479.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000243533.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000243533.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000243629.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000243629.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000243701.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000243766.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000244036.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000244040.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000244128.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000244161.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000244268.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000244286.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000244286.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000244349.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000244383.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000244459.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000244513.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000244558.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000244625.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000244649.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000244968.2 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000245059.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000245060.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000245060.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000245080.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000245105.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000245112.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000245146.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000245275.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000245311.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000245384.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000245522.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000245534.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000245552.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000245552.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000245552.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000245573.3 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000245651.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000245651.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000245768.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000245904.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000245975.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000245975.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000246090.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000246100.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000246145.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000246225.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000246263.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000246273.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000246308.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000246339.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000246375.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000246526.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000246526.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000246548.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000246695.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000246763.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000246790.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000246859.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000246863.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000246889.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000246898.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000246985.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000247081.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000247151.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000247199.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000247287.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000247317.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000247345.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000247363.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000247400.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000247516.3 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000247765.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000247775.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000247853.2 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000247934.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000247982.2 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000247982.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000248049.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000248100.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000248103.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000248103.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000248132.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000248206.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000248211.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000248238.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000248243.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000248254.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000248254.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000248356.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000248367.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000248445.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000248514.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000248515.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000248559.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000248629.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000248647.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000248663.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000248671.3 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000248690.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000248740.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000248774.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000248846.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000248846.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000248846.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000248858.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000248925.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000248936.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000248936.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000248973.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000249017.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000249096.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000249328.2 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000249345.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000249356.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000249356.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000249364.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000249375.3 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000249395.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000249413.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000249413.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000249451.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000249532.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000249593.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000249650.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000249655.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000249673.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000249684.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000249713.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000249717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000249740.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000249835.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000249849.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000249894.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000250027.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000250027.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000250081.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000250107.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000250122.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000250129.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000250132.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000250195.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000250237.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000250240.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000250362.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000250362.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000250410.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000250421.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000250508.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000250546.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000250548.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000250616.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000250659.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000250659.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000250659.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000250682.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000250699.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000250751.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000250765.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000250770.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000250802.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000250821.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000250822.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000250829.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000250838.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000250874.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000250899.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000250948.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000250948.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000250988.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000250994.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000250994.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000251085.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000251093.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000251129.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000251131.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000251144.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000251151.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000251151.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000251161.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000251164.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000251298.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000251314.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000251323.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000251363.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000251365.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000251379.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000251381.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000251381.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000251391.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000251414.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000251555.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000251586.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000251602.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000251603.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000251629.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000251661.3 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000251670.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000251867.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000253133.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000253167.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000253171.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000253194.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000253227.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000253263.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000253307.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000253390.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000253390.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000253399.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000253399.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000253405.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000253438.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000253554.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000253574.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000253618.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000253618.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000253632.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000253659.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000253671.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000253696.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000253706.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000253712.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000253730.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000253734.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000253738.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000253741.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000253741.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000253754.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000253773.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000253773.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000253837.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000253837.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000253893.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000253921.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000253961.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000253972.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000253986.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000254003.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000254008.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000254027.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000254027.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000254044.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000254263.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000254263.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000254286.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000254286.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000254286.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000254286.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000254290.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000254295.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000254317.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000254333.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000254341.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000254343.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000254414.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000254419.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000254419.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000254432.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000254432.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000254459.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000254461.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000254480.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000254495.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000254538.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000254554.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000254554.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000254606.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000254615.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000254648.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000254688.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000254693.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000254718.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000254812.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000254821.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000254833.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000254839.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000254839.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000254842.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000254936.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000254977.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000254985.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000255020.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000255026.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000255031.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000255031.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000255045.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000255045.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000255089.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000255090.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000255142.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000255145.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000255164.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000255234.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000255241.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000255247.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000255310.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000255320.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000255345.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000255421.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000255435.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000255471.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000255476.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000255487.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000255495.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000255521.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000255565.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000255580.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000255651.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000255669.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000255723.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000255741.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000255775.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000255867.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000255886.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000256025.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000256083.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000256084.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000256101.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000256115.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000256195.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000256226.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000256276.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000256299.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000256312.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000256377.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000256381.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000256381.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000256417.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000256433.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000256443.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000256452.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000256452.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000256481.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000256504.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000256542.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000256542.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000256564.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000256576.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000256576.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000256603.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000256690.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000256706.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000256712.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000256747.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000256824.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000256894.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000256943.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000256943.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000256943.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000257038.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000257038.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000257084.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000257191.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000257219.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000257252.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000257256.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000257310.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000257322.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000257391.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000257410.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000257449.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000257449.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000257497.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000257497.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000257497.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000257556.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000257595.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000257613.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000257681.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000257681.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000257696.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000257718.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000257815.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000257947.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000257953.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000258001.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000258034.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000258044.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000258044.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000258082.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000258096.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000258096.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000258136.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000258168.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000258260.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000258285.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000258302.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000258303.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000258334.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000258337.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000258378.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000258378.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000258413.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000258441.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000258450.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000258457.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000258458.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000258458.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000258525.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000258534.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000258558.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000258592.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000258623.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000258646.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000258658.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000258693.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000258698.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000258725.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000258791.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000258813.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000258813.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000258815.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000258857.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000258858.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000258859.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000258884.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000258902.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000258920.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000258920.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000258922.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000258929.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000258938.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000258959.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000258969.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000259031.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000259081.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000259081.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000259087.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000259093.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000259115.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000259116.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000259118.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000259129.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000259158.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000259172.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000259201.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000259212.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000259219.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000259230.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000259234.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000259287.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000259294.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000259306.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000259314.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000259319.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000259322.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000259343.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000259343.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000259349.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000259364.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000259376.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000259416.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000259416.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000259417.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000259438.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000259445.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000259456.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000259474.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000259485.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000259514.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000259523.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000259527.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000259540.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000259543.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000259553.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000259553.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000259563.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000259579.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000259583.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000259589.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000259594.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000259595.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000259595.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000259595.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000259596.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000259604.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000259610.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000259617.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000259644.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000259645.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000259654.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000259656.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000259659.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000259664.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000259668.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000259668.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000259678.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000259687.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000259692.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000259712.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000259715.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000259719.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000259723.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000259732.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000259736.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000259758.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000259762.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000259775.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000259782.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000259810.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000259820.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000259863.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000259883.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000259883.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000259926.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000259935.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000259942.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000260017.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000260032.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000260034.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000260046.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000260065.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000260093.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000260118.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000260141.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000260162.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000260166.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000260193.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000260231.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000260239.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000260269.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000260316.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000260329.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000260331.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000260331.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000260336.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000260351.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000260352.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000260364.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000260404.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000260409.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000260425.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000260430.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000260433.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000260464.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000260495.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000260517.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000260552.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000260572.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000260604.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000260618.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000260626.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000260630.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000260633.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000260645.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000260645.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000260660.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000260661.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000260735.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000260735.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000260743.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000260750.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000260774.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000260790.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000260803.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000260814.2 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000260831.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000260831.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000260834.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000260841.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000260841.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000260896.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000260905.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000260910.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000260917.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000260919.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000260920.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000260920.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000260924.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000260930.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000260944.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000260948.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000260954.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000260954.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000260955.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000260955.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000260976.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000260977.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000260977.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000260978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000260992.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000261015.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000261024.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000261040.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000261060.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000261064.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000261068.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000261069.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000261079.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000261083.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000261101.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000261103.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000261114.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000261126.3 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000261140.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000261159.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000261168.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000261172.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000261183.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000261186.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000261187.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000261207.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000261242.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000261254.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000261280.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000261286.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000261295.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000261298.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000261302.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000261302.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000261318.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000261324.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000261337.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000261342.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000261379.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000261404.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000261430.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000261433.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000261438.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000261441.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000261451.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000261471.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000261485.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000261505.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000261542.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000261544.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000261560.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000261584.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000261584.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000261589.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000261589.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000261616.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000261633.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000261656.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000261662.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000261673.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000261690.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000261712.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000261723.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000261731.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000261744.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000261757.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000261765.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000261765.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000261823.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000261823.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000261864.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000261886.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000261889.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000261924.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000262074.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000262115.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000262152.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000262152.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000262171.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000262222.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000262228.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000262265.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000262370.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000262445.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000262454.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000262468.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000262580.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000262585.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000262686.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000262703.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000262721.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000262745.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000262837.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000262848.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000262873.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000262873.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000262877.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000262888.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000262905.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000263011.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000263011.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000263013.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000263069.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000263072.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000263080.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000263105.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000263164.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000263182.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000263220.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000263280.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000263321.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000263327.2 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000263338.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000263388.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000263477.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000263551.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000263567.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000263624.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000263627.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000263718.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000263766.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000263786.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000263916.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000263923.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000264043.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000264078.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000264080.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000264167.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000264207.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000264269.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000264269.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000264304.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000264365.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000264448.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000264456.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000264608.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000264630.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000264647.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000264745.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000264808.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000264812.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000264920.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000264940.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000264964.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000265008.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000265185.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000265218.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000265479.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000265743.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000265750.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000265752.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000265778.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000265791.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000265800.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000265845.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000265908.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000265933.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000266049.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000266088.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000266120.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000266126.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000266313.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000266401.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000266445.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000266446.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000266601.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000266651.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000266677.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000266709.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000266709.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000266801.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000266801.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000266803.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000266803.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000266824.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000266824.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000266835.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000266901.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000266904.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000266912.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000266930.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000266934.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000266934.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000266934.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000266936.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000266936.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000266941.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000266947.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000266950.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000266957.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000266975.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000266976.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000266994.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000266999.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000267009.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000267016.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000267040.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000267053.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000267054.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000267057.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000267058.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000267096.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000267108.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000267121.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000267136.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000267150.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000267150.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000267161.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000267172.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000267174.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000267174.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000267193.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000267212.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000267213.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000267219.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000267219.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000267222.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000267244.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000267251.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000267263.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000267265.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000267272.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000267274.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000267277.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000267277.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000267278.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000267284.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000267296.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000267313.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000267322.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000267322.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000267322.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000267325.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000267327.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000267345.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000267383.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000267395.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000267405.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000267416.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000267446.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000267454.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000267461.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000267479.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000267480.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000267504.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000267510.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000267529.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000267530.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000267539.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000267546.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000267546.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000267637.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000267649.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000267649.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000267659.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000267666.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000267666.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000267666.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000267672.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000267677.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000267694.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000267702.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000267715.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000267723.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000267729.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000267730.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000267734.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000267747.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000267764.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000267787.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000267798.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000267905.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000267939.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000268006.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000268061.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000268066.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000268066.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000268087.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000268093.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000268095.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000268189.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000268204.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000268266.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000268333.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000268362.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000268364.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000268392.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000268499.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000268516.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000268530.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000268564.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000268564.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000268568.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000268573.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000268583.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000268649.2 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000268650.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000268658.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000268683.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000268707.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000268743.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000268756.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000268764.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000268836.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000268895.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000268895.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000268912.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000268912.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000268913.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000268931.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000268970.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000268970.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000269051.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000269054.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000269066.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000269082.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000269091.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000269148.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000269148.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000269172.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000269202.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000269235.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000269293.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000269303.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000269365.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000269365.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000269399.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000269423.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000269425.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000269463.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000269486.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000269487.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000269560.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000269652.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000269737.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000269802.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000269814.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000269836.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000269836.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000269843.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000269892.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000269893.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000269896.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000269896.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000269898.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000269900.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000269902.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000269902.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000269903.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000269910.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000269911.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000269918.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000269919.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000269923.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000269925.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000269940.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000269947.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000269994.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000270001.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000270012.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000270015.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000270018.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000270022.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000270031.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000270039.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000270041.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000270062.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000270068.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000270071.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000270072.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000270091.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000270104.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000270108.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000270116.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000270130.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000270140.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000270177.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000270178.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000270184.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000270189.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000270195.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000270223.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000270426.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000270557.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000270571.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000270580.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000270599.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000270605.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000270704.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000270755.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000270761.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000270761.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000270883.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000270933.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000270933.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000270933.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000270949.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000270949.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000271032.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000271032.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000271133.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000271151.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000271199.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000271208.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000271324.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000271359.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000271359.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000271384.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000271398.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000271427.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000271430.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000271576.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000271593.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000271631.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000271659.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000271734.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000271742.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000271755.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000271757.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000271778.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000271778.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000271778.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000271781.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000271782.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000271803.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000271815.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000271821.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000271826.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000271833.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000271833.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000271835.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000271843.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000271843.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000271851.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000271856.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000271871.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000271882.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000271889.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000271912.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000271913.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000271914.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000271914.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000271921.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000271927.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000271964.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000271983.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000271997.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000271997.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000272005.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000272010.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000272023.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000272040.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000272048.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000272068.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000272072.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000272081.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000272093.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000272109.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000272112.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000272121.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000272130.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000272141.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000272141.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000272142.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000272167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000272218.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000272219.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000272219.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000272221.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000272225.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000272235.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000272235.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000272265.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000272301.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000272308.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000272308.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000272320.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000272328.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000272335.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000272343.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000272343.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000272361.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000272386.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000272416.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000272417.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000272432.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000272438.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000272446.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000272446.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000272449.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000272452.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000272457.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000272473.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000272489.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000272489.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000272520.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| RO-3306 |
ENSG00000272520.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000272562.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000272562.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000272610.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000272610.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000272630.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000272639.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000272646.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000272682.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000272682.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000272682.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000272689.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000272717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000272732.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000272769.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000272777.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000272784.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000272788.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000272800.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000272810.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000272829.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000272834.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000272849.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000272861.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000272862.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000272872.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000272872.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000272885.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000272902.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000272905.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000272908.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000272913.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000272917.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000272927.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000272933.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000272954.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000272983.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000272995.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000273004.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000273007.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000273008.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000273015.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000273018.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000273018.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000273027.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000273032.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000273056.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000273059.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| RO-3306 |
ENSG00000273065.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000273073.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000273091.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000273096.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000273108.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000273116.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| RO-3306 |
ENSG00000273125.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000273132.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000273133.1 |
Predicted lncRNA |
Esophageal cancer |
|
| RO-3306 |
ENSG00000273148.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000273164.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000273179.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000273183.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000273216.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000273218.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000273248.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000273253.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000273265.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000273290.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000273295.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000273295.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000273295.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000273297.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000273301.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000273308.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000273311.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000273319.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| RO-3306 |
ENSG00000273321.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000273325.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000273342.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000273343.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000273343.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000273343.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000273350.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| RO-3306 |
ENSG00000273355.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000273355.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| RO-3306 |
ENSG00000273375.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| RO-3306 |
ENSG00000273384.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| RO-3306 |
ENSG00000273406.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000273406.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000273416.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000273424.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| RO-3306 |
ENSG00000273437.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| RO-3306 |
ENSG00000273443.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000273464.1 |
Predicted lncRNA |
Sarcoma |
|
| RO-3306 |
ENSG00000273472.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| RO-3306 |
ENSG00000273483.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| RO-3306 |
ENSG00000273492.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
